Beneficial effects of short-term calorie restriction against cisplatin-induced acute renal injury in aged rats

Nephron - Experimental Nephrology

Volumn 124, Issue 3-4, 2014, Pages 19-27

  Ning, Yi Chun ^a,b   Cai, Guang Yan ^a   Zhuo, Li ^a   Gao, Jian Jun ^a   Dong, Dan ^a   Cui, Shao Yuan ^a   Shi, Suo Zhu ^a   Feng, Zhe ^a   Zhang, Li ^a   Sun, Xue Feng ^a   Chen, Xiang Mei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Acute kidney injury; Apoptosis; Calorie restriction; Cisplatin

Indexed keywords

CASPASE 3; CISPLATIN; CREATININE; SIRTUIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CALORIC RESTRICTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FOOD INTAKE; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY STRUCTURE; KIDNEY TUBULE CELL; MALE; MORPHOMETRICS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SENESCENCE; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY FAILURE; AGED; ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; BODY WEIGHT; RENAL PROTECTION;

ACUTE KIDNEY INJURY; AGING; ANIMALS; APOPTOSIS; CALORIC RESTRICTION; CASPASE 3; CISPLATIN; CREATININE; DISEASE MODELS, ANIMAL; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIRTUIN 1; TREATMENT OUTCOME;

EID: 84896714023     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000357380     Document Type: Article

References (37)

1. Muggia FM: Cisplatin update. Semin Oncol 1991; 18: 1-4.
2. Gadducci A, Brunetti I, Bruzzone M, Carnino F, Chiara S, Conte PF, Fioretti P, Foglia G, Ragni N: Cisplatin-based combination chemotherapy with or without doxorubicin in advanced epithelial ovarian cancer: 8-year update of a randomized multicentric clinical trial. The Gruppo Oncologico Nord Ovest (GONO). Eur J Gynaecol Oncol 1992; 13: 36-39.
3. Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 2003; 23: 460-464. (Pubitemid 37176691)
4. Mohan IK, Khan M, Shobha JC, Naidu MU, Prayag A, Kuppusamy P, Kutala VK: Protection against cisplatin-induced nephrotoxicity by spirulina in rats. Cancer Chemother Pharmacol 2006; 58: 802-808. (Pubitemid 44351261)
5. Omodei D, Fontana L: Calorie restriction and prevention of age-associated chronic disease. FEBS Lett 2011; 585: 1537-1542.
6. Longo VD, Fontana L: Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci 2010; 31: 89-98.
7. Weindruch R, Sohal RS: Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med 1997; 337: 986-994.
8. Masoro EJ: Caloric restriction and aging: an update. Exp Gerontol 2000; 35: 299-305. (Pubitemid 30314687)
9. Peng W, Robertson L, Gallinetti J, Mejia P, Vose S, Charlip A, Chu T, Mitchell JR: Surgical stress resistance induced by single amino acid deprivation requires Gcn2 in mice. Sci Transl Med 2012; 4: 118ra111.
10. Kaushal GP, Kaushal V, Herzog C, Yang C: Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity. Autophagy 2008; 4: 710-712.
11. Do Amaral CL, Francescato HD, Coimbra TM, Costa RS, Darin JD, Antunes LM, Bianchi Mde L: Resveratrol attenuates cisplatininduced nephrotoxicity in rats. Arch Toxicol 2008; 82: 363-370.
12. Maines MD, Raju VS, Panahian N: Spin trap (N-t-butyl-alpha-phenylnitrone) -mediated suprainduction of heme oxygenase-1 in kidney ischemia/reperfusion model: role of the oxygenase in protection against oxidative injury. J Pharmacol Exp Ther 1999; 291: 911-919. (Pubitemid 29503569)
13. Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Lee SY, Han MK, Kim DH, Kim W: Sirt1 overexpression decreases cisplatin-induced acetylation of NF-kappaB p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem Biophys Res Commun 2012; 419: 206-210.
14. Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W: Sirt1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 2011; 301:F427-F435.
15. Tauchi H, Tsuboi K, Okutomi J: Age changes in the human kidney of the different races. Gerontologia 1971; 17: 87-97.
16. Long DA, Mu W, Price KL, Johnson RJ: Blood vessels and the aging kidney. Nephron Exp Nephrol 2005; 101:e95-e99. (Pubitemid 41540697)
17. Qiao X, Chen XM, Wu D, Ding R, Wang J, Hong Q, Shi S, Li J, Xie Y, Lu Y, Wang Z: Mitochondrial pathway is responsible for agingrelated increase of tubular cell apoptosis in renal ischemia/reperfusion injury. J Gerontol A Biol Sci Med Sci 2005; 60: 830-839. (Pubitemid 41098626)
18. Cui J, Bai XY, Shi S, Cui S, Hong Q, Cai G, Chen X: Age-related changes in the function of autophagy in rat kidneys. Age (Dordr) 2012; 34: 329-339.
19. Brandhorst S, et al: Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp Gerontol 2013; 48: 1120-1128.
20. Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, Hwang D, Cohen P, Bianchi G, Longo VD: Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res 2010; 70: 1564-1572.
21. Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, Longo VD: Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci USA 2008; 105: 8215-8220. (Pubitemid 351904737)
22. Santos NA, Catao CS, Martins NM, Curti C, Bianchi ML, Santos AC: Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch Toxicol 2007; 81: 495-504. (Pubitemid 47012464)
23. Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL: Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci 2008; 101: 159-170. (Pubitemid 350239020)
24. Espandiari P, Zhang J, Rosenzweig BA, Vaidya VS, Sun J, Schnackenberg L, Herman EH, Knapton A, Bonventre JV, Beger RD, Thompson KL, Hanig J: The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity. Toxicol Sci 2007; 99: 637-648. (Pubitemid 351753077)
25. Beytur A, Kose E, Sarihan ME, Sapmaz HI, Dogan Z, Cetin A, Vardi N, Turkoz Y, Ekinci N: Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats. Ren Fail 2012; 34: 343-349.
26. Beytur A, Ciftci O, Oguz F, Oguzturk H, Yilmaz F: Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats. Cancer Chemother Pharmacol 2012; 69: 207-213.
27. Sawhney P, Giammona CJ, Meistrich ML, Richburg JH: Cisplatin-induced long-term failure of spermatogenesis in adult C57/Bl/6J mice. J Androl 2005; 26: 136-145. (Pubitemid 39665287)
28. Atessahin A, Sahna E, Turk G, Ceribasi AO, Yilmaz S, Yuce A, Bulmus O: Chemoprotective effect of melatonin against cisplatin-induced testicular toxicity in rats. J Pineal Res 2006; 41: 21-27. (Pubitemid 43980691)
29. Ma H, Jones KR, Guo R, Xu P, Shen Y, Ren J: Cisplatin compromises myocardial contractile function and mitochondrial ultrastructure: role of endoplasmic reticulum stress. Clin Exp Pharmacol Physiol 2010; 37: 460-465.
30. Kaushal GP, Kaushal V, Hong X, Shah SV: Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 2001; 60: 1726-1736. (Pubitemid 32999977)
31. Nowak G: Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem 2002; 277: 43377-43388. (Pubitemid 35285726)
32. Martin-Montalvo A, de Cabo RD: Mitochondrial metabolic reprogramming induced by calorie restriction. Antioxid Redox Signal 2013; 19: 310-320.
33. Harhaji-Trajkovic L, Arsikin K, Kravic-Stevovic T, Petricevic S, Tovilovic G, Pantovic A, Zogovic N, Ristic B, Janjetovic K, Bumbasirevic V, Trajkovic V: Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation. Pharm Res 2012; 29: 2249-2263.
34. Lee C, Raffaghello L, Brandhorst S, Safdie FM, Bianchi G, Martin-Montalvo A, Pistoia V, Wei M, Hwang S, Merlino A, Emionite L, de Cabo R, Longo VD: Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 2012; 4: 124-27.
35. Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, Conti PS, Chen TC, Longo VD: Fasting enhances the response of glioma to chemo-and radiotherapy. PLoS One 2012; 7:e44603.
36. Lopez-Dominguez JA, Khraiwesh H, Gonzalez-Reyes JA, Lopez-Lluch G, Navas P, Ramsey JJ, de Cabo R, Buron MI, Villalba JM: Dietary fat modifies mitochondrial and plasma membrane apoptotic signaling in skel-etal muscle of calorie-restricted mice. Age (Dordr) 2012; 35: 2027-2044.
37. Sakao Y, Kato A, Tsuji T, Yasuda H, Togawa A, Fujigaki Y, Kahyo T, Setou M, Hishida A: Cisplatin induces Sirt1 in association with histone deacetylation and increased Werner syndrome protein in the kidney. Clin Exp Nephrol 2011; 15: 363-372.